Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Avicanna Inc (AVCN.TO)

Avicanna Inc (AVCN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avicanna Inc 480 University Avenue Suite 1502 Toronto BC M5G 1V2 CAN

https://www.avicanna.com P: 647-243-5283

Description:

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Key Statistics

Overview:

Market Capitalization, $K 30,468
Shares Outstanding, K 106,906
Annual Sales, $ 16,791 K
Annual Net Income, $ -8,743 K
Last Quarter Sales, $ 6,123 K
Last Quarter Net Income, $ -1,945 K
60-Month Beta 0.15
% of Institutional Shareholders 0.00%

Growth:

1-Year Return -29.27%
3-Year Return -62.34%
5-Year Return -93.39%
5-Year Revenue Growth 169.56%

Per-Share Information:

Most Recent Earnings -0.03 on 08/14/24
Next Earnings Date N/A
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Year -53.54%
Dividend Payout Ratio 0.00%

AVCN.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,064.26%
Return-on-Assets % -35.85%
Profit Margin % -52.07%
Debt/Equity N/A
Price/Sales 1.07
Price/Book 895.99
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar